Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T07:03:58.221Z Has data issue: false hasContentIssue false
  • English
  • Français

Prediction of Recurrent Clostridium Difficile Infection Using Comprehensive Electronic Medical Records in an Integrated Healthcare Delivery System

Published online by Cambridge University Press:  24 August 2017

Gabriel J. Escobar ,
Jennifer M. Baker ,
Patricia Kipnis ,
John D. Greene ,
T. Christopher Mast ,
Swati B. Gupta ,
Nicole Cossrow ,
Vinay Mehta ,
Vincent Liu  and
Erik R. Dubberke
Gabriel J. Escobar*
Affiliation:
Kaiser Permanente Division of Research, Oakland, California
Jennifer M. Baker
Affiliation:
Contra Costa Public Health Clinic Services, Martinez, California
Patricia Kipnis
Affiliation:
Kaiser Permanente Division of Research, Oakland, California Kaiser Permanente Northern California, Oakland, California
John D. Greene*
Affiliation:
Kaiser Permanente Division of Research, Oakland, California
T. Christopher Mast
Affiliation:
Merck Research Laboratories, North Wales, Pennsylvania
Swati B. Gupta
Affiliation:
Merck Vaccines, West Point, Pennsylvania
Nicole Cossrow
Affiliation:
Merck Research Laboratories, North Wales, Pennsylvania
Vinay Mehta
Affiliation:
Merck Research Laboratories, North Wales, Pennsylvania
Vincent Liu
Affiliation:
Kaiser Permanente Division of Research, Oakland, California Santa Clara Medical Center and Medical Offices, Kaiser Permanente Northern California, Santa Clara, California
Erik R. Dubberke
Affiliation:
Washington University School of Medicine, St Louis, Missouri
*
Address correspondence to Gabriel J. Escobar, MD, Systems Research Initiative, Kaiser Permanente Division of Research, 2000 Broadway Ave (032 R01), Oakland, CA 94612-2304 (gabriel.escobar@kp.org) or John Greene, MA, Systems Research Initiative, Kaiser Permanente Northern California Division of Research, 2000 Broadway Ave, Oakland, CA 94612 (john.d.greene@kp.org).
Address correspondence to Gabriel J. Escobar, MD, Systems Research Initiative, Kaiser Permanente Division of Research, 2000 Broadway Ave (032 R01), Oakland, CA 94612-2304 (gabriel.escobar@kp.org) or John Greene, MA, Systems Research Initiative, Kaiser Permanente Northern California Division of Research, 2000 Broadway Ave, Oakland, CA 94612 (john.d.greene@kp.org).
Get access Rights & Permissions [Opens in a new window]

Abstract

BACKGROUND

Predicting recurrent Clostridium difficile infection (rCDI) remains difficult. METHODS. We employed a retrospective cohort design. Granular electronic medical record (EMR) data had been collected from patients hospitalized at 21 Kaiser Permanente Northern California hospitals. The derivation dataset (2007–2013) included data from 9,386 patients who experienced incident CDI (iCDI) and 1,311 who experienced their first CDI recurrences (rCDI). The validation dataset (2014) included data from 1,865 patients who experienced incident CDI and 144 who experienced rCDI. Using multiple techniques, including machine learning, we evaluated more than 150 potential predictors. Our final analyses evaluated 3 models with varying degrees of complexity and 1 previously published model.

RESULTS

Despite having a large multicenter cohort and access to granular EMR data (eg, vital signs, and laboratory test results), none of the models discriminated well (c statistics, 0.591–0.605), had good calibration, or had good explanatory power.

CONCLUSIONS

Our ability to predict rCDI remains limited. Given currently available EMR technology, improvements in prediction will require incorporating new variables because currently available data elements lack adequate explanatory power.

Infect Control Hosp Epidemiol 2017;38:1196–1203

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 38 , Issue 10 , October 2017 , pp. 1196 - 1203
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Lessa, FC, Winston, LG, McDonald, LC. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372:2369–2370.Google Scholar
2. Kwon, JH, Olsen, MA, Dubberke, ER. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am 2015;29:123–134.Google Scholar
3. Olsen, MA, Young-Xu, Y, Stwalley, D, et al. The burden of Clostridium difficile infection: estimates of the incidence of CDI from US administrative databases. BMC Infect Dis 2016;16:177.Google Scholar
4. Freedberg, DE, Salmasian, H, Cohen, B, Abrams, JA, Larson, EL. Receipt of antibiotics in hospitalized patients and risk for Clostridium difficile infection in subsequent patients who occupy the same bed. JAMA Intern Med 2016;176:1801–1808.Google ScholarPubMed
5. McFarland, LV. Renewed interest in a difficult disease: Clostridium difficile infections—epidemiology and current treatment strategies. Curr Opin Gastroenterol 2009;25:24–35.Google Scholar
6. Bouza, E. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin Microbiol Infect 2012;18(Suppl 6):5–12.Google Scholar
7. McFarland, LV, Elmer, GW, Surawicz, CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002;97:1769–1775.Google Scholar
8. Zilberberg, MD, Reske, K, Olsen, M, Yan, Y, Dubberke, ER. Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infect Dis 2014;14:306.Google Scholar
9. Sheitoyan-Pesant, C, Abou Chakra, CN, Pepin, J, Marcil-Heguy, A, Nault, V, Valiquette, L. Clinical and healthcare burden of multiple recurrences of Clostridium difficile infection. Clin Infect Dis 2016;62:574–580.Google Scholar
10. Hu, MY, Katchar, K, Kyne, L, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology 2009;136:1206–1214.Google Scholar
11. Eyre, DW, Walker, AS, Wyllie, D, et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clin Infect Dis 2012;55:S77–S87.Google Scholar
12. Hebert, C, Du, H, Peterson, LR, Robicsek, A. Electronic health record–based detection of risk factors for Clostridium difficile infection relapse. Infect Control Hosp Epidemiol 2013;34:407–414.Google Scholar
13. D’Agostino, RB Sr., Collins, SH, Pencina, KM, Kean, Y, Gorbach, S. Risk estimation for recurrent Clostridium difficile infection based on clinical factors. Clin Infect Dis 2014;58:1386–1393.Google Scholar
14. Kollef, MH, Chen, Y, Heard, K, et al. A randomized trial of real-time automated clinical deterioration alerts sent to a rapid response team. J Hosp Med 2014;9:424–429.Google Scholar
15. Escobar, GJ, Dellinger, RP. Early detection, prevention, and mitigation of critical illness outside intensive care settings. J Hosp Med 2016;11:S5–S10.Google Scholar
16. Escobar, GJ, Turk, BJ, Ragins, A, et al. Piloting electronic medical record-based early detection of inpatient deterioration in community hospitals. J Hosp Med 2016;11:S18–S24.Google Scholar
17. Watt, M, Dinh, A, Le Monnier, A, Tilleul, P. Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France. J Med Econ 2017;20:678–686.Google Scholar
18. Nelson, RL, Suda, KJ, Evans, CT. Antibiotic treatment for Clostridium difficile–associated diarrhoea in adults. Cochrane Database Syst Rev 2017;3:CD004610.Google Scholar
19. Wilcox, MH, Gerding, DN, Poxton, IR, et al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Eng. J Med 2017;376:305–317.Google Scholar
20. Escobar, GJ, Greene, JD, Gardner, MN, Marelich, GP, Quick, B, Kipnis, P. Intra-hospital transfers to a higher level of care: contribution to total hospital and intensive care unit (ICU) mortality and length of stay (LOS). J Hosp Med 2011;6:74–80.Google Scholar
21. Liu, V, Kipnis, P, Rizk, NW, Escobar, GJ. Adverse outcomes associated with delayed intensive care unit transfers in an integrated healthcare system. J Hosp Med 2012;7:224–230.Google Scholar
22. Escobar, GJ, Gardner, MN, Greene, JD, Draper, D, Kipnis, P. Risk-adjusting hospital mortality using a comprehensive electronic record in an integrated health care delivery system. Med Care 2013;51:446–453.Google Scholar
23. Selby, JV. Linking automated databases for research in managed care settings. Ann Intern Med 1997;127:719–724.Google Scholar
24. Deyo, RA, Cherkin, DC, Ciol, MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.Google ScholarPubMed
25. Zilberberg, MD, Reske, K, Olsen, M, Yan, Y, Dubberke, ER. Development and validation of a recurrent Clostridium difficile risk-prediction model. J Hosp Med 2014;9:418–423.Google Scholar
26. Dubberke, ER, Reske, KA, Yan, Y, Olsen, MA, McDonald, LC, Fraser, VJ. Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 2007;45:1543–1549.Google Scholar
27. Dubberke, ER, Yan, Y, Reske, KA, et al. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol 2011;32:360–366.Google Scholar
28. Hastie, T, Tibshirani, R, Friedman, JH. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. 2nd ed. New York: Springer Verlag; 2009.Google Scholar
29. Allison, PD. Logistic Regression Using SAS: Theory and Application. 2nd ed. Cary, NC: SAS Institute; 2012.Google Scholar
30. Hastie, T, Tibshirani, R, Friedman, J, Franklin, J. The elements of statistical learning: data mining, inference and prediction. Mathemat Intelligenc 2005;27:83–85.Google Scholar
31. Hosmer, DW, Lemeshow, S. Applied Survival Analysis: Regression Modelling of Time to Event Data. Hoboken, NJ: Wiley; 2008.Google Scholar
32. Cook, DA, Duke, G, Hart, GK, Pilcher, D, Mullany, D. Review of the application of risk-adjusted charts to analyse mortality outcomes in critical care. Crit Care Resusc 2008;10:239–251.Google Scholar
33. Crowson, CS, Atkinson, EJ, Therneau, TM. Assessing calibration of prognostic risk scores. Stat Method Med Res 2014;25:1692–1706.Google Scholar
34. Cook, NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928–935.Google Scholar
35. Pencina, MJ, D’Agostino, RB Sr, D’Agostino, RB Jr, Vasan, RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157–172; discussion 207–212.Google Scholar
36. Estrella, A, Mishkin, FS. Predicting US recessions: financial variables as leading indicators. Rev Econ Statist 1998;80:45–61.Google Scholar
37. McDonald, EG, Milligan, J, Frenette, C, Lee, TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile Infection. JAMA Intern Med 2015;175:784–791.Google Scholar
38. Deshpande, A, Pasupuleti, V, Thota, P, et al. Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2015;36:452–460.Google Scholar
39. Kuntz, JL, Johnson, ES, Raebel, MA, et al. Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score. Clin Microbiol Infect 2015;21:256–262.Google Scholar
40. Kuntz, JL, Smith, DH, Petrik, AF, et al. Predicting the risk of Clostridium difficile infection upon admission: a score to identify patients for antimicrobial stewardship efforts. Perm J 2016;20:20–25.Google Scholar
Supplementary material: File

Escobar et al supplementary material

Appendix

Download Escobar et al supplementary material(File)
File 250.8 KB